Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
IL-17F and IL-17A are members of the IL-17 pro-inflammatory cytokine family. IL-17A has been implicated in the pathogenesis of autoimmune diseases. IL-17F is a disulfide-linked dimer that contains a cysteine-knot motif. We hypothesized that IL-17F and IL-17A could form a heterodimer due to their sequence homology and overlapping pattern of expression. We evaluated the structure of recombinant IL-17F and IL-17A proteins, as well as that of natural IL-17F and IL-17A derived from activated human CD4+ T cells, by enzyme-linked immunosorbent assay, immunoprecipitation followed by Western blotting, and mass spectrometry. We find that both IL-17F and IL-17A can form both homodimeric and heterodimeric proteins when expressed in a recombinant system, and that all forms of the recombinant proteins have in vitro functional activity. Furthermore, we find that in addition to the homodimers of IL-17F and IL-17A, activated human CD4+ T cells also produce the IL-17F/IL-17A heterodimer. These data suggest that the IL-17F/IL-17A heterodimer may contribute to the T cell-mediated immune responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A, -AF and -F trigger qualitatively similar signaling pathways, however IL-17A homodimers induce a far more potent signal compared to IL-17F homodimers, with IL-17AF thought to be intermediate signaling strength”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Wright et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
Cited by
Items 201–300 of 318
Asahina, A., Okubo, Y., Morita, A., Tada, Y., Igarashi, A., Langley, R. G. B., Deherder, D., Matano, M., Vanvoorden, V., Wang, M., et al. (2023) · Dermatology and Therapy · doi:10.1007/s13555-022-00883-y · Cited by 20
Zhou, C., Wu, D., Jawale, C. V., Li, Y., Biswas, P. S., McGeachy, M. J., & Gaffen, S. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155715 · Cited by 24
Epitope‐Targeted Macrocyclic Peptide Ligand with Picomolar Cooperative Binding to Interleukin‐17F
Lai, B. T., Wilson, J. A., Loredo, J. M., Pitram, S. M., LaBerge, N. A., Heath, J. R., & Agnew, H. D. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201704752 · Cited by 20
Songhet, P., Barthel, M., Röhn, T. A., Maele, L. V., Cayet, D., Sirard, J., Bachmann, M. F., Köpf, M., & Hardt, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013804 · Cited by 18
“It is known that IL-17A and IL-17F differ significantly in terms of their threshold concentration required for inducing IL-17RA-mediated responses [30,35,36,37].”
BackgroundKisand, K. E., & Peterson, P. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000028 · Cited by 19
Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors
Liu, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9367-9_5 · Cited by 20
Yeung, J., Bunce, P. E., Lynde, C. W., Turchin, I., & Vender, R. B. (2022) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754221111111 · Cited by 18
Takahashi, Y., Okamura, Y., Morimoto, N., Mihara, K., Maekawa, S., Wang, H., Aoki, T., Kono, T., Sakai, M., & Hikima, J.-I. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.05.016 · Cited by 17
Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development
Theune, W. C., Ju, C. A., Theune, E. V., Ye, X., Ménoret, A., Vella, A. T., & Wang, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1408710 · Cited by 19
Numasaki, M., Tsukamoto, H., Tomioka, Y., Nishioka, Y., & Ohrui, T. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.240.47 · Cited by 15
Rationalizing heptadecaphobia: TH17 cells and associated cytokines in cancer and metastasis
Lücke, J., Shiri, A. M., Zhang, T., Kempski, J., Giannou, A. D., & Huber, S. (2021) · FEBS Journal · doi:10.1111/febs.15711 · Cited by 14
Saini, C., Srivastava, R. K., Kumar, P., Ramesh, V., & Sharma, A. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154873 · Cited by 15
Geoghegan, K. F., Song, X., Hoth, L. R., Feng, X., Shanker, S., Quazi, A., Luxenberg, D. P., Wright, J. F., & Griffor, M. C. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.09.013 · Cited by 14
Zhou, C., Monin, L., Gordon, R. A., Aggor, F. E. Y., Bechara, R., Edwards, T. N., Kaplan, D. H., Gingras, S., & Gaffen, S. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000394 · Cited by 14
The role of heterodimer IL 17A/F in atopic dermatitis
Krzysiek, J., Lesiak, A., Szybka, M., Michalak, A., Pastuszak‐Lewandoska, D., Grzegorczyk, J., Ciążyńska, M. A., & Narbutt, J. (2022) · Advances in Dermatology and Allergology · doi:10.5114/ada.2022.122604 · Cited by 17
“suggested that heterodimers are even more potent than IL-17A in enhancing chemokine expression [41].”
BackgroundTh17 cells in rheumatoid arthritis
Himer, L., Balog, A., Szebeni, B., Szakál, D. N., Sziksz, E., Reusz, G., Tulassay, T., & Vannay, Á. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28880 · Cited by 14
Expression, refolding and purification of a human interleukin-17A variant
Wu, B., Nemeth, J. F., Janecki, D. J., Jones, B. H., Obmolova, G., Malia, T., Baker, A. E., Bethea, D., Elloso, M. M., Naso, M. F., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.07.002 · Cited by 15
“While both IL-17A and IL-17F are homodimers, IL17A/F heterodimers have also been found [8].”
BackgroundHan, C., Gunn, G. R., Marini, J. C., Shankar, G., Hsu, H. H., & Davis, H. M. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062679 · Cited by 15
“It was previously reported that human IL-17A/F may form hetero- or homodimers (Wright et al., 2007) at higher concentrations (i.e., nanograms per milliliter).”
BackgroundRen, T., Feng, H., Xu, Y., & Ling, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118267 · Cited by 13
Rheumatoid arthritis bone marrow environment supports Th17 response
Kuca‐Warnawin, E., Kurowska, W., Prochorec‐Sobieszek, M., Radzikowska, A., Burakowski, T., Skalska, U., Massalska, M., Plebańczyk, M., Małdyk-Nowakowska, B., Słowińska, I., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1483-x · Cited by 13
“These results support other authors’ observations that IL-17A exists mainly as an IL-17AF heterodimer [19].”
ResultVelcicky, J., Bauer, M. R., Schlapbach, A., Lapointe, G., Meyer, A., Vögtle, M., Blum, E., Ngo, E. O., Rolando, C., Nimsgern, P., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01520 · Cited by 12
IL-17RA in Intestinal Inflammation: Structure, Signaling, Function, and Clinical Application
Liu, S., Ren, J., & Li, J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000217 · Cited by 14
Saitoh, K., Kon, S., Nakatsuru, T., Inui, K., Ihara, T., Matsumoto, N., Kitai, Y., Muromoto, R., & Matsuda, T. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.08.021 · Cited by 14
Ghali, J. R., O’Sullivan, K. M., Eggenhuizen, P. J., Holdsworth, S. R., & Kitching, A. R. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000453059 · Cited by 13
Walliser, I., & Göbel, T. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.03.006 · Cited by 15
Role of IL-17A and neutrophilic granulocytes in the pathogenesis of psoriasis
Smolyannikova, V. A., Karamova, A. Е., & Nefedova, M. A. (2020) · Russian Journal of Archive of Pathology · doi:10.17116/patol20208201130 · Cited by 13
Mouse Th17 cells: Current understanding of their generation and regulation
Dong, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200839076 · Cited by 11
Pu, J., Xu, J., Chen, L., Zhou, H., Cao, W., Hao, B., Li, N., Wu, J., Zheng, J., Hong, W., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.010 · Cited by 12
Nisar, H., Attique, S. A., Javaid, A., Ain, Q. U., Butt, F., Zaid, M., Shahid, S., Nasir, M. H., & Sadaf, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2173299 · Cited by 10
“Both A and F subunits of IL17 family share 50% sequence identity and expressed as either homodimers or as a heterodimer (IL17A/F) (Chang & Dong, 2007; Wright et al., 2007).”
BackgroundIL-17C as a Driver of Inflammation in Psoriasis
Han, G., Armstrong, A. W., Krueger, J. G., & Jacobson, A. A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03363-9 · Cited by 10
“IL-17A IL-17A and IL-17F form homodimers and heterodimers and act synergistically [28, 33–35].”
Corbière, V., Lambert, E. E., Rodesch, M., den Brink, J. A. M. V. G.-V., Misiak, A., Simonetti, E. R., Praet, A. V., Godefroid, A., Diavatopoulos, D. A., van Els, C. A. C. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1101366 · Cited by 10
“was combined to investigate Th17 responses (46).”
Polymorphisms in Th17-related genes and the pathogenesis of autoimmune thyroid disease
Kunisato, T., Watanabe, M., Inoue, N., Okada, A., Nanba, T., Kobayashi, W., Inoue, Y., Katsumata, Y., Omori, N., Nobuhara, T., et al. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1534963 · Cited by 9
“IL-17A and IL-17F have similar functions [53].”
Role of T H 17 Responses in Increasing Herpetic Keratitis in the Eyes of Mice Infected with HSV-1
Hirose, S., Jaggi, U., Wang, S., Tormanen, K., Nagaoka, Y., Katsumata, M., & Ghiasi, H. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.6.20 · Cited by 9
The Th17 lineage: Answers to some immunological questions
González‐García, C., Martín-Saavedra, F. M., Ballester, A., & Ballester, S. (2009) · Inmunología · doi:10.1016/s0213-9626(09)70025-3 · Cited by 12
“IL17A and IL-17F work mostly as homodimers, but IL-17A/F heterodimers have been recently described in several independent reports(6-8), suggesting a role in inflammatory response regulation for such IL-17 complexes.”
BackgroundZhao, Q., Jiang, H., Ma, T., Qiu, H., Guo, M., & Zhang, X. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22893 · Cited by 12
Use of Brodalumab for the Treatment of Psoriasis and Psoriatic Arthritis
Kivelevitch, D. N., & Menter, A. (2015) · Immunotherapy · doi:10.2217/imt.14.113 · Cited by 11
IL-17 in skin infections and homeostasis
García-Patiño, M. G., Marcial-Medina, C., Ruiz-Medina, B. E., & Licona-Limón, P. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110352 · Cited by 11
Regulation of Interleukin-17 Production
Dong, W., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_7 · Cited by 7
Jondle, C. N., & Tarakanova, V. L. (2022) · Journal of Virology · doi:10.1128/jvi.00639-22 · Cited by 6
The IL-17 axis in gastric carcinogenesis: From inflammation to oncogenic transformation
Lyu, Z., Gu, M., Lu, Z., Lin, F., Zhang, R., Dong, P., Liu, Y., Li, Z., & Huang, L. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.12.001 · Cited by 6
Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome
Gisondi, P., Fratton, Z., da Rosa, R. V., Bellini, V., & Carugno, A. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2026.2673285 · Cited by 8
Preclinical development of GR1501, a human monoclonal antibody that neutralizes interleukin-17A
Shan, Y., Shi, K., Qian, X., Zhiyuan, C., Yang, J., Gao, Y., Jin, W., Luo, Q., & Xu, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.078 · Cited by 7
TH17 Cytokines: Characteristics, Regulation, and Biological Function
Angkasekwinai, P., & Dong, C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_2 · Cited by 9
“However, our group and others reported that IL-17A and IL-17F were not only secreted as homodimeric proteins but can also form heterodimers in both human and mouse (Chang and Dong 2007; Liang et al. 2007; Wright et al. 2007).”
Backgroundγδ T cell-stromal networks modulate matrix composition and vascularity in foreign body response
Ruta, A., Krishnan, K., Woo, J., Mejías, J. C., Gray-Gaillard, E. F., Maestas, D. R., Nguyen, H. H., Rindone, A. N., Cherry, C., Patatanian, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71540-7 · Cited by 6
Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis
Warren, R. B., Hunter, H. J. A., Papp, K. A., Gordon, K. B., Tang, M. T., Enejosa, J., Huang, K.-C., Raha, D., Batugedara, H., Skinner, C., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341049 · Cited by 6
Lu, Y., Xu, F., Qi, F., & Pan, Y. (2026) · Biomolecules · doi:10.3390/biom16030414 · Cited by 5
“IL-17A is frequently co-expressed with IL-17F, sharing approximately 50% sequence homology [20].”
Han, X., Su, X., Che, M., Liu, L., Nie, P., & Wang, S. (2025) · Genes · doi:10.3390/genes16030253 · Cited by 5
“IL-17A homodimers, IL-17F homodimers, or IL-17A/F heterodimers send signals through IL-17RA/IL-17RC [12,13].”
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis
Galluzzo, M., Talamonti, M., D’Adamio, S., & Bianchi, L. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1325874 · Cited by 5
Allegretta, C., Montemitro, E., Ciciriello, F., Altieri, M. T., Sabbioni, G., Breveglieri, G., Borgatti, M., Cabrini, G., & Laselva, O. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.104926 · Cited by 4
Wan, S., Sun, Z., Zhang, C., Pan, T., Yuan, S., Chen, Y., Zou, J., & Gao, Q. (2023) · Fishes · doi:10.3390/fishes8080405 · Cited by 4
Moog, M., Baltes, M., Bormann, T., Aschenbrenner, F., Maus, R., Stolper, J., Jonigk, D. D., Prinz, I., Kolb, M. R. J., & Maus, U. A. (2024) · European Journal of Immunology · doi:10.1002/eji.202451323 · Cited by 5
“These cytokines appear to signal through a ternary complex with the IL-17RA and IL-17RC receptors [8–10].”
Analysis of IL-17 Production by Flow Cytometry and ELISPOT Assays
Zhao, L., Chou, Y. K., Jiang, Y., Jiang, Z., & Chu, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0928-5_22 · Cited by 4
Huss, N. P., Majeed, S. T., Wills, B. M., Tarakanova, V. L., Brockman, K. L., & Jondle, C. N. (2024) · Virology · doi:10.1016/j.virol.2024.110153 · Cited by 4
ASSESSMENT OF THE ROLE OF IL-17A IN RHEUMATOID ARTHRITIS PATIENTS; IN SULAYMANIYAH GOVERNORATE
Tofiq, D. M., & Merza, R. R. (2015) · European Scientific Journal ESJ · Cited by 4
Molecular aspects of the T-helpers type 17 functioning
Кологривова, И. В., Коlogrivova, Y. N., & Суслова, Т. Е. (2011) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2011-4-93-98 · Cited by 7
Interleukin-17F: A Promising Candidate of Cancer Therapy
Yan, H. (2012) · ImmunoGastroenterology · doi:10.7178/ig.17 · Cited by 3
Multiple Roles of the Interleukin IL-17 Members in Breast Cancer and Beyond
Potteaux, S., Lehmann‐Che, J., Bensussan, A., Naour, R. L., & Merrouche, Y. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.1.020 · Cited by 4
“The IL-17F homodimer is 100-fold less active than the IL-17A homodimer, but its expression was shown to be 10-fold higher than the IL-17A homodimer form, in the conditioned medium of human activated CD4+ T cells [15].”
BackgroundHuang, W., Zhou, Y., Pan, C., Zhang, X., Zhao, H., & Shen, L. (2023) · Journal of Molecular Recognition · doi:10.1002/jmr.3045 · Cited by 5
Иркиновна, С. Е., Каладзе, Н. Н., & Говдалюк, А. Л. (2017) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2017-21-2-73-82 · Cited by 3
Majeed, S. T., Huss, N. P., Bradford, S. M., & Jondle, C. N. (2025) · Journal of Virology · doi:10.1128/jvi.01842-25 · Cited by 1
“Intriguingly, SARS-CoV-2’s viral protein Orf8 acts as a viral mimic of host IL-17 to activate IL-17RA and IL-17RC (39).”
The tissue-specific regulation of immunobiology by IL-17 signaling
Li, Y., Vyas, S., Dráber, P., Bechara, R., & Gaffen, S. L. (2026) · Science Immunology · doi:10.1126/sciimmunol.adq6406 · Cited by 2
IL-17 Receptor inhibition with brodalumab limits experimental periodontitis
Valverde, A. M., Naqvi, R. A., Tokarski, M., Ceredon, K., Gluck, J., Elshourbagy, S., Martínez, G., Brambilla, M., Nares, S., Schwartz, J., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08657-2 · Cited by 2
IL-17A and Th17 cells as therapeutic targets for autoimmune diseases
Padova, F. D. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8681-8_19 · Cited by 2
“The picture might be further complicated by the presence of IL-17A/F heterodimers [ 19 ].”
BackgroundTargeting interleukin-17 in the lungs
Ivanov, S., & Lindén, A. (2010) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000320813 · Cited by 2
IL-17A Family, Receptors, Proinflammatory Effects, and Production
Padova, F. D., Ryffel, B., & Quesniaux, V. F. J. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_1 · Cited by 2
Ćirić, B., & Rostami, A. M. (2010) · The Open Autoimmunity Journal · Cited by 2
IL-23/TH17 Pathway in Psoriasis and Inflammatory Skin Diseases
Nograles, K. E., Davidovici, B. B., & Krueger, J. G. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_25 · Cited by 2
“While both IL-17A and IL-17F form covalent homodimers, recent findings have shown that they can also form IL-17A-IL-17F heterodimeric complexes ( Wright et al. 2007; Chang and Dong 2007).”
BackgroundKorppi, M. O., Teräsjärvi, J. T., Liehu‐Martiskainen, M., Barkoff, A., Lauhkonen, E., Huhtala, H., Pöyhönen, L., Nuolivirta, K., & He, Q. (2020) · Acta Paediatrica · doi:10.1111/apa.15574 · Cited by 2
IL-17 Inhibition in Axial Spondyloarthritis
Danve, A. S., & Deodhar, A. A. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0020-9 · Cited by 2
Yang, G. H., & Huang, Y. (2021) · Springer eBooks · doi:10.1007/978-981-33-4838-7_6 · Cited by 1
Sarrand, J., Baglione, L., Bouvy, C., & Soyfoo, M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052315 · Cited by 3
“This results in the transcriptional activation of pro-inflammatory mediators, such as IL-6, IL-8, and TNF-α [29,30].”
From Large to Small Cytokine Receptor Antagonists
Leźnicki, P., Deacon, K., Waszkowycz, B., & Unitt, J. F. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100280 · Cited by 1
Cytokine multimerization: when more is more and sometimes less
Rudloff, I., Christie, M., Deen, N. S., Ellisdon, A. M., Nold‐Petry, C. A., & Nold, M. F. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01290-6 · Cited by 4
“IL-17 family cytokines form homodimers (for example, IL17A–IL-17A, IL17B–IL-17B), but heterodimeric combinations are reported (for example, IL-17A–IL-17F) 226 (Table 2).”
Elzubeir, A., Patel, M., & Rushbrook, S. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104095 · Cited by 3
IL-17A as a Therapeutic Target for Autoimmune Diseases
Padova, F. D., & Carballido, J. M. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_24 · Cited by 1
Weissert, R. (2010) · Future Neurology · doi:10.2217/fnl.10.32 · Cited by 1
THE ROLE OF THE IL-17/IL-17R AXIS IN BREAST TUMOR GROWTH AND METASTASIS
Dawod, B. (2016) · DalSpace (Dalhousie University) · Cited by 1
Cui, Y., Yu, L., Wang, F., Shen, X.-L., & Yang, G. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.04.027 · Cited by 1
Effects of Qingli Gandan decoction on IL-23/IL-17 in rats with experimental autoimmune uveitis
Wang, Q., Juan, G. A. O., ZHANG, Y.-L., Wang, X., & Pang, Y. (2022) · Food Science and Technology · doi:10.1590/fst.69122 · Cited by 1
T HELPER 17 CELLS IN MULTIPLE SCLEROSIS AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Bălașa, R. (2010) · Cited by 1
Targeting the IL-17/IL-23 Axis in Chronic Inflammatory Immune-Mediated Diseases
Tsoukas, A., Goodyear, C. S., & McInnes, I. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00028-x · Cited by 4
Lai, Y., & Dong, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10014-1 · Cited by 1
The functional biology of IL-25
Saenz, S. A. (2011) · Scholarly Commons (University of Pennsylvania)
Almazán, M. J. B. (2012) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/1902 · Cited by 1
Etiological and clinical studies of Langerhans Cell Histiocytosis (LCH)
Åkefeldt, S. O. (2013) · Figshare
Importance of Th17‐ and Th1‐Associated Responses for the Development of Asthma
Yoshimoto, T., Tsutsui, H., & Nakanishi, K. (2011) · Wiley eBooks · doi:10.1002/9781444346688.ch3
IL-17 Receptor Family: Structure, Signal Transduction, and Function
Shen, F. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_3
Structure and IL-17 Receptor Signaling
Tsang, M., & Gaffen, S. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_9
Aricò, M., Henter, J., Egeler, R. M., & Delprat, C. (2009) · Nature Medicine · doi:10.1038/nm0509-484
Lipopolysaccharide-Mediated Regulation of IL-17 Receptor Levels in Human Monocytes
Zhang, X. (2011) · QSpace (Queen's University Library)
FEEDBACK INHIBITION OF IL-17 RECEPTOR SIGNAL TRANSDUCTION
Garg, A. V. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Ong, J. S. (2013) · University of Liverpool · doi:10.17638/00008733
Signal Transduction and TH17 Cell Differentiation
Yang, X., O’Shea, J. J., Ghoreschi, K., & Laurence, A. D. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_8 · Cited by 1
Zhao, E., Wang, L., Wei, S., Kryczek, I., & Zou, W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00010-5
Gizinski, A. M., & Fox, D. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00063-4
Chu, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28040-0_1
Gizinski, A. M., & Fox, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00065-6
The IL23-Th17 Axis in Intestinal Inflammation
Maloy, K. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8256-7_11
Tram, C. (2018) · DalSpace (Dalhousie University)
Metadata
- Authors
- Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., Carreno, B. M., Collins, M., & Wolfman, N. M.
- Affiliations
- Wyeth (US)
- Corresponding author
- Carreno, Beatriz M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 18
- Pages
- 13447-13455
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2091653067
- Cited by
- 319
- References
- 36
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 9 · 2017: 16 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 21 · 2012: 25
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4932 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17F, IL-17A, CD4+ T cells, T cell activation, cytokine structure, T cell immunity, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Cricetulus, Cysteine, Gene Expression Regulation, Cricetinae, Humans, Immunity, Cellular, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Gene Expression, CHO Cells, Dimerization, Interleukin-17, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.